SEC Form 4 · accession 0001209191-16-125573
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lynch
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2016 | A | 1,400 | $0.00 | A | 1,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $47.87 | Jun 2, 2016 | A | 5,600 | D | — | Jun 2, 2026 | Common Stock | 5,600 | 5,600 | D |
Explanation of responses
- F1These restricted stock unts for common stock vest 100% on the earlier of June 2, 2017, or the date of the next annual meeting of stockholders.
- F2This option vests 100% on the earlier of June 2, 2017, or the date of the next annual meeting of stockholders.